LCN2 as an inflammatory marker can activate the STAT3 signaling pathway by its receptor 24p3R to exacerbate insulin resistance, nonalcoholic steatohepatitis and obesity43,54. This evidence concerns the gene SLC22A17 and metabolic dysfunction-associated steatohepatitis.